BioNTech SE (BNTX) Interest & Investment Income (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Interest & Investment Income data on file, last reported at $115.9 million in Q4 2025.

• For the quarter ending Q4 2025, Interest & Investment Income fell 34.32% year-over-year to $115.9 million; the trailing twelve-month figure through Dec 2025 stood at $477.4 million (down 34.09% YoY), and the FY2025 full-year result was $478.9 million, down 32.5% from the prior year.
• Interest & Investment Income advanced to $115.9 million in Q4 2025, from $113.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $305.4 million in Q1 2022 to a low of $361281.4 in Q2 2021.
• A 5-year average of $120.5 million and a median of $121.3 million in 2022 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income jumped 34013.31% in 2022 and slumped 71.07% in 2023, its largest moves.
• Tracing BNTX's Interest & Investment Income over 5 years: stood at $18.6 million in 2021, then soared by 112.29% to $39.6 million in 2022, then jumped by 340.86% to $174.5 million in 2023, then advanced by 1.15% to $176.5 million in 2024, then slumped by 34.32% to $115.9 million in 2025.
• Business Quant data shows BNTX's Interest & Investment Income at $115.9 million in Q4 2025, $113.2 million in Q3 2025, and $119.3 million in Q2 2025.